Department of Hepatobiliary Surgery;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
Department of Imaging;
Jinan City People's Hospital;
Shandong First Medical University;
Jinan 271199;
Shandong Province;
China;
Programmed cell death 1/programmed cell death ligand 1 inhibitors; Targeted therapy; Hepatocellular carcinoma; Programmed cell death 1; Programmed cell death ligand 1;